UNICEF paying for the drugs to limit impact of shortages on vulnerable countries
The U.N. Children’s Fund (UNICEF) is negotiating the advance purchase under the deal led by UNITAID and Wellcome, as part of the World Health Organization’s plan to accelerate access to therapeutics, Reuters reports quoting a joint statement issued on Friday.
The statement said an initial purchase of the steroid dexamethasone, shown to be effective in treating severe or critical COVID-19 patients, will be made for up to 4.5 million people in low- and middle-income countries, agencies said on Friday.
READ ALSO: Nigeria COVID-19 data suggest second lockdown is inevitable, but Nigerians disagree
“With this advanced purchase we aim to ensure equitable access for low- and middle-income countries for the treatment of COVID-19 with the life-saving drug dexamethasone, and avoid shortages resulting from high levels of demand from other parts of the world,” said Philippe Duneton, acting executive director of UNITAID.
